🔏 Sign prescription
✕
Signing PIN
Confirm new PIN
⚙ Display
✕
Text size
Small
Standard
Large
XL
Colour scheme
Dark
Light
High contrast
← Back
Prescription
🖨 Print / Save PDF
OncoTide
Choose how you'd like to continue
🎓 Training mode
Practice with sample patients — no real data, no login required
🏥 Live system
Real patients — requires sign-in and MFA
OncoTide
🌙
Username
Password
Sign in →
Invalid credentials
Forgot your password?
🎓 Training mode
v158
Two-factor login
Scan this with your authenticator app, then enter the 6-digit code below.
6-digit code
Verify →
Invalid code — try again
Reset password
Enter your username — we'll email a reset link to the address on file.
Username
Send reset link →
Unknown username
Check your email for a reset link.
← Back to sign in
Set new password
New password
Confirm new password
Set password →
Passwords don't match
🎓 Training mode
Enter the shared training password to continue. No real data is used in this mode.
Training password
Enter training mode →
Incorrect password
← Back to sign in
Which role would you like to practice as?
👨⚕️ Prescriber
💊 Pharmacist
🩺 Nurse
🔧 Admin
🎓 TRAINING MODE — sample data only, nothing here is real
OncoTide
⬡
Core
⚙
🌙
⟳ Refresh
🔍
⚙
⏻
Good morning
⇄ Cover / handover
—
My patients
Tap to view →
—
Need prescribing
Tap to view →
—
Awaiting pharmacy
Tap to view →
—
Ready to administer
Tap to view →
Recent patients
▸
Upcoming cycles
Sort: due date
Sort: name
Sort: regimen
▸
Action required
View all →
📅
Day unit schedule
Loading occupancy…
→
My patients
Unit patients
Inactive
+
←
‹
›
drag tabs to reorder
Analytics
All lines
1st line
2nd line
3rd line+
All regimens
All tumours
Lung
Breast
Colorectal
Bladder
Renal
Prostate
Genitourinary
Head & Neck
Melanoma
Upper GI
Pancreas
Gynaecological
Haematology
All intents
Curative
Neo-adjuvant
Adjuvant
Palliative
All responses
CR
PR
SD
PD
Responders (CR+PR)
Apply
↓ Trial CSV
Reports
↓ CSV
Last 30 days
Last 90 days
Last 6 months
Last 12 months
All time
All tumour types
Lung
Breast
Colorectal
Genitourinary
Head & Neck
Melanoma
Upper GI
Pancreas
Gynaecological
Haematology
All consultants
Dr W. Ince
Dr E. dos Santos
Dr D. Lee
Dr M. Butt
Dr R. Soomal
Dr L. Grimes
All intents
Curative
Palliative
Neo-adjuvant
Adjuvant
Apply
— Select patient —
Audit Log
⌂
Dashboard
👥
Patients
🔬
Analytics
📊
Reports
📋
Audit
📅
Schedule
Edit clinical details
✕
Diagnosis
Significant comorbidities
Care alerts
+ Add a care alert…
Difficult IV access
Central line / PICC in situ
Port-a-cath in situ
Lymphoedema — avoid this arm
Cold cap requested
Cold gloves/socks requested
Needle phobia
Interpreter required
Hearing/visual impairment
Falls risk
Mobility aid required
Cognitive impairment
Lives alone
Latex allergy
MRSA positive
Anticoagulated
DNACPR in place
Register patient
✕
First name *
Last name *
Hospital number
Date of birth *
Sex
Male
Female
Intent
Curative
Neo-adjuvant
Adjuvant
Palliative
Primary oncologist *
— Select consultant —
Dr Will Ince
Dr Dan Lee
Dr Elizabet dos Santos
Dr Rubin Soomal
Dr Mohammad Butt
Other
Tumour type
Lung
Breast
Colorectal
Haematology
Upper GI
Genitourinary
Head & Neck
Melanoma
Gynaecological
Pancreas
Other
Diagnosis *
ICD-10 code *
Key biomarkers
Stage at diagnosis
— Select —
I
II
III
IIIA
IIIB
IV
IVA
IVB
Metastatic (unstaged)
Locally advanced
Not applicable
Allergies *
Weight (kg)
Height (cm)
Creatinine (μmol/L)
Bilirubin (μmol/L)
↻ Change regimen
✕
⚠ Document the clinical reason before switching. This will be recorded in the patient's treatment history.
Reason for change *
— Select reason —
Disease progression — radiological
Disease progression — clinical
Completion of planned course — switching to maintenance
Unacceptable toxicity — grade 3/4
Toxicity — cumulative, dose-limiting
Patient choice / preference
Organ dysfunction — dose modification insufficient
Treatment break — planned re-challenge with different agent
Clinical trial enrolment
Change to best supportive care
Other (see notes)
Clinical notes
New regimen
— Select new regimen —
Or enter regimen name
■ End treatment
✕
This will mark the patient as off active systemic treatment. The treatment history is preserved.
Reason *
— Select reason —
Completion of planned course — no further treatment planned
Disease progression — no further systemic options
Patient choice — declined further treatment
Performance status decline — no longer fit for SACT
Unacceptable toxicity — treatment permanently stopped
Switching to best supportive care / palliative care
Death
Lost to follow-up
Transfer of care
End date
Notes
Response assessment
✕
Assessment date *
Modality
CT chest/abdomen/pelvis
CT chest
MRI
PET-CT
Bone scan
Clinical assessment
Biochemical (PSA/CA125/CEA)
Endoscopy
Other
RECIST 1.1 response *
CR
Complete response
PR
Partial response
SD
Stable disease
PD
Progressive disease
Sum of target lesions (mm)
Sum of longest diameters — baseline and current
Tumour marker (if applicable)
— None —
PSA
CA125
CEA
CA19-9
AFP
LDH
Beta-HCG
AFP+Beta-HCG
Is this a progression event?
Mark as progression event (PFS endpoint)
Records progression date for PFS calculation
Clinical notes
Log adverse event
✕
CTCAE term *
Fatigue
Nausea
Vomiting
Diarrhoea
Constipation
Mucositis oral
Peripheral neuropathy
Peripheral sensory neuropathy
Peripheral motor neuropathy
Pain
Alopecia
Rash maculo-papular
Rash acneiform
Palmar-plantar erythrodysaesthesia
Pruritus
Dry skin
Nail changes
Neutropenia
Anaemia
Thrombocytopenia
Febrile neutropenia
Lymphopenia
ALT increased
AST increased
Bilirubin increased
Creatinine increased
Proteinuria
Hypertension
Hypotension
Cardiac failure
QTc prolongation
Venous thromboembolism
Pulmonary embolism
Deep vein thrombosis
Pneumonitis
Dyspnoea
Cough
Colitis
Enterocolitis
Hypothyroidism
Hyperthyroidism
Adrenal insufficiency
Hypophysitis
Hyperglycaemia
Hypoglycaemia
Hypomagnesaemia
Hypokalaemia
Hyponatraemia
Hypocalcaemia
Infusion related reaction
Anaphylaxis
Arthralgia
Myalgia
Myositis
Weight loss
Anorexia
Oedema limb
Oedema face
CTCAE grade *
1
Mild
2
Moderate
3
Severe
4
Life-threatening
5
Death
Onset date
Resolution date
Attribution
Related — definitely/probably related to treatment
Possible — possibly related to treatment
Unlikely — unlikely related to treatment
Unrelated — not related to treatment
Category
General
Immune-related (irAE)
Haematological
Gastrointestinal
Neurological
Dermatological
Endocrine
Hepatic
Renal
Cardiac
Pulmonary
Metabolic
Action taken
No action — monitoring only
Dose reduction
Dose omission (this cycle)
Treatment hold
Drug discontinued permanently
Treatment discontinued
Systemic steroids commenced
Hospitalisation required
Supportive care only
Notes / management
Record outcome
✕
Outcome type *
— Select —
Death
Alive — last follow-up
Lost to follow-up
Withdrawn from care
Date *
Cause of death
Disease progression
Treatment-related toxicity
Unrelated cause
Unknown
Was death treatment-related?
No
Yes — treatment-related death
Possibly treatment-related
Notes
Plan next regimen
✕
📋 Plan a future regimen — e.g. nivolumab maintenance after ipi/nivo C4, or 2nd line on progression. Select from the library or enter free text.
Select from regimen library
— Pick a regimen —
Or enter regimen name (if not in library)
Intention / line of treatment
Trigger / condition to start
Add premedication
✕
Custom
Drug name
Dose
Route
Timing
Note
⚙ Settings
✕
Appearance
Dark / Light mode
Toggle display theme
🌙 Dark
Dashboard
Show upcoming cycles
Cycles due for your patients
Show pending pharmacy
Prescriptions awaiting verification
Alert days threshold
Highlight cycles due within X days
3 days
5 days
7 days
14 days
Patient view
Default tab on opening patient
Which tab opens first
Overview
Tx History
Prescribe
Cycles
Default patient list
Which list shows on opening patients
My patients
Unit patients
Account
📅 Book appointment
✕
Date *
Time *
Chair / room
⏸ Defer cycle
✕
Reason *
— Select —
Haematological toxicity — neutropenia
Haematological toxicity — thrombocytopenia
Renal impairment — eGFR below threshold
Hepatic toxicity — elevated LFTs
Immune-related adverse event (irAE)
Electrolyte imbalance requiring correction
Active infection / sepsis
Patient unwell — intercurrent illness
Patient request
Logistical / scheduling
Other (see notes)
Notes
Review date
Enter value
✕
Modify dose
✕
Calculated dose
—
—
Omit this drug
Not given this or subsequent cycles until restored
Quick reduction
100%
—
75%
—
50%
—
25%
—
Or type the actual dose you want to give
mg
Reason for modification (mandatory)
— Select standard reason or type below —
G2 neutropenia
G3/4 neutropenia
Febrile neutropenia
G3/4 thrombocytopenia
Anaemia
G2 peripheral neuropathy
G3 peripheral neuropathy
Renal impairment
Hepatic impairment
Elevated creatinine
G2 mucositis
G3 diarrhoea
Nausea/vomiting
Hand-foot syndrome
Cardiac toxicity
Hypertension
Cumulative toxicity
Patient request
PS decline
Declining DLCO
Cumulative dose limit
Allergy/hypersensitivity
Flag for review at next cycle (alert on next prescription)
Modify premedication
✕
Standard prescribed dose
—
—
Omit — do not give
Remove from this cycle's prescription
New dose
mg
Change summary
—
Reason (mandatory)
+ Add TTO
✕
💊 Medications for the patient to take home
Custom TTO
Drug name
Dose & frequency
Route
Supply
💧 Supportive infusions
✕
↺
